FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Reviewing Post-market Safety of Parkinsons Drug

FDA begins a post-marketing safety evaluation of Acadia Pharmaceuticals Parkinsons drug Nuplazid (pimavanserin) based on safety reports, including 700...

Human Drugs

FDA Approves Hologic ThinPrep Integrated Imager

FDA approves a Hologic PMA for the ThinPrep Integrated Imager for automated imaging of Pap tests.

Human Drugs

Saranas De Novo App Filed for Early Bleed Monitor

Saranas files a de novo classification for the Early Bird Bleed Monitoring System, a device for use during endovascular procedures to detect the onset...

Human Drugs

Inter Partes Process Likely to Continue for Biologics: Attorneys

A Supreme Court decision in an energy company patent case may result in continued use of inter partes review by companies challenging biologics patent...

Medical Devices

Bayer Submits Updated Essure Postmarket Report

Bayer sends FDA an updated Essure study interim postmarket surveillance report.

FDA General

Budget Increase to Bolster Generics, Real World Data: Gottlieb

FDA commissioner Scott Gottlieb tells Senate appropriators that the Trump Administrations proposed fiscal year 2019 budget increase of $663 million (1...

Supreme Court Acts in 2 FCA Cases

Attorney Jennifer Thomas describes actions taken by the Supreme Court in two False Claims Act cases affecting FDA-regulated products.

Medical Devices

Risk of Tissue Overheating with Some MR Devices: FDA

FDA cautions healthcare providers that magnetic resonance-guided laser interstitial thermal therapy devices may give inaccurate temperature readings, ...

Human Drugs

Report Highlights Research Priorities for Transdermal Generics

A new CDER report on developing generic drug transdermal delivery systems examines current and future research opportunities.

Human Drugs

Placebo Trials Can Put Subjects at Risk: New Study

A Public Citizen study cautions that clinical trial participants in placebo-only controlled trials of new drugs for life-threatening diseases for whic...